MedTrace Logo

China ATTUNE® Study

NCT03542045 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-04-14

No results posted yet for this study

Summary

The study was designed as prospective, single-arm, multi-center which was intended to broadly capture all patients as the technology is adopted.

Conditions

Interventions

DEVICE

Cemented ATTUNE® Knee System

This product is for total knee arthroplasty. Four implant configurations are permitted: Cruciate Retaining Fixed Bearing (CR FB), Cruciate Retaining Rotating Platform (CR RP), Posterior Stabilizing Fixed Bearing (PS FB) and Posterior Stabilizing Rotating Platform (PS RP)

Sponsors & Collaborators

  • DePuy Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Shudong Zhang · Yantaishan Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-12
Primary Completion
2021-11-19
Completion
2021-11-19
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03542045 on ClinicalTrials.gov